Literature DB >> 20207720

Acetaminophen elimination half-life in humans is unaffected by short-term consumption of sulfur amino acid-free diet.

Yanci O Mannery1, Thomas R Ziegler, Youngja Park, Dean P Jones.   

Abstract

Sulfation and glutathione (GSH) conjugation are important pathways for elimination of acetaminophen (APAP). Previous studies in rodents show that limitation of dietary sulfur amino acids (SAAs) reduces biosynthesis of 3'-phosphoadenosine-5'-phosphosulfate, the precursor for sulfation, and GSH, the precursor for the mercapturatic acid pathway. The amount of SAA needed for the metabolism of two doses of APAP is equivalent to 62% of the recommended dietary allowance (RDA) for SAA in humans. A decrease in the activity of these metabolic pathways could lead to decreased elimination of the reactive metabolite of APAP and possibly affect risk of APAP use. To determine whether intake of a SAA-deficient diet alters APAP metabolism, a pilot clinical study with a double-blind, cross-over design was performed. Subjects received the RDA for SAA for 3 days for equilibration. After admission to the clinical research unit, subjects were given a chemically defined diet with 100 or 0% of the RDA for SAA for 2 days. On day 3, two doses of APAP (15 mg/kg) or placebo were given successively within a 6-h interval. Plasma samples were collected at baseline and hourly for 12 h, and two 6-h urine aliquots were collected during this time course. The data show that SAA limitation 1) did not change the pattern of APAP metabolites in plasma or urine and 2) did not alter APAP pharmacokinetics. Thus, the results show that 2 days of diet completely devoid of SAA have no effect on APAP metabolism or disposition in healthy humans.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20207720      PMCID: PMC2879925          DOI: 10.1124/jpet.110.166439

Source DB:  PubMed          Journal:  J Pharmacol Exp Ther        ISSN: 0022-3565            Impact factor:   4.030


  21 in total

1.  Effects of sulfur-amino acid-deficient diets on acetaminophen metabolism and hepatotoxicity in rats.

Authors:  V F Price; D J Jollow
Journal:  Toxicol Appl Pharmacol       Date:  1989-11       Impact factor: 4.219

2.  The fate of acetanilide in man.

Authors:  B B BRODIE; J AXELROD
Journal:  J Pharmacol Exp Ther       Date:  1948-09       Impact factor: 4.030

Review 3.  The ontogeny of human drug-metabolizing enzymes: phase II conjugation enzymes and regulatory mechanisms.

Authors:  D Gail McCarver; Ronald N Hines
Journal:  J Pharmacol Exp Ther       Date:  2002-02       Impact factor: 4.030

4.  Sinusoidal efflux of glutathione in the perfused rat liver. Evidence for a carrier-mediated process.

Authors:  M Ookhtens; K Hobdy; M C Corvasce; T Y Aw; N Kaplowitz
Journal:  J Clin Invest       Date:  1985-01       Impact factor: 14.808

5.  Intracellular proatherogenic events and cell adhesion modulated by extracellular thiol/disulfide redox state.

Authors:  Young-Mi Go; Dean P Jones
Journal:  Circulation       Date:  2005-05-31       Impact factor: 29.690

6.  Dietary glutathione intake in humans and the relationship between intake and plasma total glutathione level.

Authors:  E W Flagg; R J Coates; J W Eley; D P Jones; E W Gunter; T E Byers; G S Block; R S Greenberg
Journal:  Nutr Cancer       Date:  1994       Impact factor: 2.900

7.  Hepatobiliary excretion of acetaminophen glutathione conjugate and its derivatives in transport-deficient (TR-) hyperbilirubinemic rats.

Authors:  Chuan Chen; Gayle E Hennig; Jose E Manautou
Journal:  Drug Metab Dispos       Date:  2003-06       Impact factor: 3.922

Review 8.  Variability in glutathione-dependent detoxication in vivo and its relevance to detoxication of chemical mixtures.

Authors:  D P Jones; L A Brown; P Sternberg
Journal:  Toxicology       Date:  1995-12-28       Impact factor: 4.221

9.  Redox control of platelet aggregation.

Authors:  David W Essex; Mengru Li
Journal:  Biochemistry       Date:  2003-01-14       Impact factor: 3.162

10.  Sulfation of acetaminophen and acetaminophen-induced alterations in sulfate and 3'-phosphoadenosine 5'-phosphosulfate homeostasis in rats with deficient dietary intake of sulfur.

Authors:  Z Gregus; H J Kim; C Madhu; Y Liu; P Rozman; C D Klaassen
Journal:  Drug Metab Dispos       Date:  1994 Sep-Oct       Impact factor: 3.922

View more
  4 in total

1.  Aggregate culture of human embryonic stem cell-derived hepatocytes in suspension are an improved in vitro model for drug metabolism and toxicity testing.

Authors:  Srikumar Sengupta; Brian Patrick Johnson; Scott Allen Swanson; Ron Stewart; Christopher Alan Bradfield; James Alexander Thomson
Journal:  Toxicol Sci       Date:  2014-04-20       Impact factor: 4.849

2.  An Unexpected Role of Cholesterol Sulfotransferase and its Regulation in Sensitizing Mice to Acetaminophen-Induced Liver Injury.

Authors:  Yunqi An; Pengcheng Wang; Pengfei Xu; Hung-Chun Tung; Yang Xie; Levent Kirisci; Meishu Xu; Songrong Ren; Xin Tian; Xiaochao Ma; Wen Xie
Journal:  Mol Pharmacol       Date:  2019-04-03       Impact factor: 4.436

3.  Favipiravir inhibits acetaminophen sulfate formation but minimally affects systemic pharmacokinetics of acetaminophen.

Authors:  Yanli Zhao; Jerold S Harmatz; Carol R Epstein; Yukako Nakagawa; Chie Kurosaki; Tetsuro Nakamura; Takumi Kadota; Dennis Giesing; Michael H Court; David J Greenblatt
Journal:  Br J Clin Pharmacol       Date:  2015-06-08       Impact factor: 4.335

4.  Co-culture with mouse embryonic fibroblasts improves maintenance of metabolic function of human small hepatocyte progenitor cells.

Authors:  Srikumar Sengupta; Brian Johnson; Morten Seirup; Hamisha Ardalani; Bret Duffin; Gregory A Barrett-Wilt; Ron Stewart; James A Thomson
Journal:  Curr Res Toxicol       Date:  2020-08-26
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.